anti-MAdCAM-1 CAR T-cell therapy (Kyverna Therapeutics)

N/A

Report date: 2025/03/14 18:13:44

Base Information

Drug Nameanti-MAdCAM-1 CAR T-cell therapy (Kyverna Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionMucosal addressin cell adhesion molecule-1 modulators

TargetsMucosal addressin cell adhesion molecule-1

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKyverna Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKyverna Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A